APA (7th ed.) Citation

CG, J., K, S., PI, T., A, O., BA, R., DJ, P., . . . MP, F. (2014). Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: A multi-centre phase II study. BMC cancer, 14, 737. https://doi.org/10.1186/1471-2407-14-737

Chicago Style (17th ed.) Citation

CG, Jackson, et al. "Dose-intense Capecitabine, Oxaliplatin and Bevacizumab as First Line Treatment for Metastatic, Unresectable Colorectal Cancer: A Multi-centre Phase II Study." BMC Cancer 14 (2014): 737. https://doi.org/10.1186/1471-2407-14-737.

MLA (9th ed.) Citation

CG, Jackson, et al. "Dose-intense Capecitabine, Oxaliplatin and Bevacizumab as First Line Treatment for Metastatic, Unresectable Colorectal Cancer: A Multi-centre Phase II Study." BMC Cancer, vol. 14, 2014, p. 737, https://doi.org/10.1186/1471-2407-14-737.